Yr Athro Timothy Bowen

2023

• Smith, D. A., Redman, J. E., Fraser, D. J. and Bowen, T. 2023. Identification and detection of microRNA kidney disease biomarkers in liquid biopsies. Current Opinion in Nephrology and Hypertension 32(6), pp. 515-521. (10.1097/MNH.0000000000000927)
• Grigorieva, I., Woods, E. L., Steadman, R., Bowen, T. and Meran, S. 2023. Hyaluronan in kidney fibrosis. In: Passi, A. ed. Hyaluronan: Structure, Biology and Biotechnology., Vol. 14. Biology of Extracellular Matrix Springer, pp. 77-97., (10.1007/978-3-031-30300-5_5)

2022

• Wonnacott, A., Denby, L., Coward, R. J. M., Fraser, D. J. and Bowen, T. 2022. MicroRNAs and their delivery in diabetic fibrosis. Advanced Drug Delivery Reviews 182, article number: 114045. (10.1016/j.addr.2021.114045)

2021

• Lu, Y. et al. 2021. Single-nucleus RNA sequencing identifies new classes of proximal tubular epithelial cells in kidney fibrosis. Journal of the American Society of Nephrology 32(10), pp. 2501-2516. (10.1681/ASN.2020081143)
• Woods, E. L. et al. 2021. CD147 mediates the CD44s-dependent differentiation of myofibroblasts driven by transforming growth factor-β1. Journal of Biological Chemistry 297(3), article number: 100987. (10.1016/j.jbc.2021.100987)
• Newbury, L. J. et al. 2021. miR-141 mediates recovery from acute kidney injury. Scientific Reports 11(1), article number: 16499. (10.1038/s41598-021-94984-x)
• Smith, D. A. et al. 2021. Detection of urinary microRNA biomarkers using diazo sulfonamide-modified screen printed carbon electrodes. RSC Advances 11(31), pp. 18832-18839. (10.1039/D0RA09874D)
• Khalid, U. et al. 2021. Determination of a microRNA signature of protective kidney ischemic preconditioning originating from proximal tubules. Scientific Reports 11(1), article number: 9862. (10.1038/s41598-021-89195-3)

2019

• Brook, A. C. et al. 2019. Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis. Scientific Reports 9, article number: 10136. (10.1038/s41598-019-46585-y)
• Khalid, U. et al. 2019. A urinary microRNA panel that is an early predictive biomarker of delayed graft function following kidney transplant. Scientific Reports 9, article number: 3584. (10.1038/s41598-019-38642-3)

2018

• Thomas, M., Fraser, D. and Bowen, T. 2018. Biogenesis, stabilization, and transport of microRNAs in kidney health and disease. Non-Coding RNA 4(4), pp. 30., article number: 30. (10.3390/ncrna4040030)
• Beltrami, C. et al. 2018. Association of elevated urinary miR-126, miR-155, and miR-29b with diabetic kidney disease. American Journal of Pathology 188(9), pp. 1982-1992. (10.1016/j.ajpath.2018.06.006)

2017

• Smith, D., Newbury, L., Drago, G., Bowen, T. and Redman, J. E. 2017. Electrochemical detection of urinary microRNAs via sulfonamide-bound antisense hybridisation. Sensors and Actuators B: Chemical 253, pp. 335-341. (10.1016/j.snb.2017.06.069)
• Wonnacott, A., Bowen, T. and Fraser, D. 2017. MicroRNAs as biomarkers in chronic kidney disease. Current Opinion in Nephrology and Hypertension 26(6), pp. 460-466. (10.1097/MNH.0000000000000356)
• Lopez-Anton, M. et al. 2017. miR-21 promotes fibrogenesis in peritoneal dialysis. American Journal of Pathology 187(7), pp. 1537-1550. (10.1016/j.ajpath.2017.03.007)
• Lopez Anton, M. et al. 2017. Telomere length profiles in primary human peritoneal mesothelial cells are consistent with senescence. Mechanisms of Ageing and Development 164, pp. 37-40. (10.1016/j.mad.2017.03.010)

2016

• Liuzzi, A. R. et al. 2016. Unconventional human T cells accumulate at the site of infection in response to microbial ligands and induce local tissue remodeling. Journal of Immunology 197(6), pp. 2195-2207. (10.4049/jimmunol.1600990)
• Martin, J., Midgley, A., Meran, S., Woods, E., Bowen, T., Phillips, A. O. and Steadman, R. 2016. Tumour necrosis factor-stimulated gene (TSG)-6-mediated interactions with the inter-alpha-inhibitor heavy chain 5 facilitate TGF beta1-dependent fibroblast to myofibroblast differentiation.. Journal of Biological Chemistry 291, pp. 13789-13801. (10.1074/jbc.M115.670521)
• Simpson, K., Wonnacott, A., Fraser, D. J. and Bowen, T. 2016. MicroRNAs in diabetic nephropathy: from biomarkers to therapy. Current Diabetes Reports 16(3), article number: 35. (10.1007/s11892-016-0724-8)
• Khalid, U., Ablorsu, E., Szabo, L., Jenkins, R. H., Bowen, T., Chavez, R. and Fraser, D. J. 2016. MicroRNA-21 (miR-21) expression in hypothermic machine perfusate may be predictive of early outcomes in kidney transplantation. Clinical Transplantation 30(2), pp. 99-104. (10.1111/ctr.12679)
• Chavez, R., Fraser, D. J., Bowen, T., Jenkins, R. H., Nesargikar, P., Pino-Chavez, G. and Khalid, U. 2016. Kidney ischaemia reperfusion injury in the rat: the EGTI scoring system as a valid and reliable tool for histological assessment. Journal of Histology and Histopathology 3, article number: 1. (10.7243/2055-091X-3-1)

2015

• Khalid, U., Jenkins, R. H., Simpson, K., Ablorsu, E., Bowen, T., Fraser, D. J. and Chavez, R. 2015. Urinary microrna expression predicts delayed graft function in kidney transplantation [Abstract]. Transplant International 28(S4), pp. 367-367. (10.1111/tri.12702)
• Beltrami, C. et al. 2015. Stabilization of urinary microRNAs by association with exosomes and argonaute 2 protein. Non-Coding RNA 1(2), pp. 151-166. (10.3390/ncrna1020151)
• Jenkins, R., Liao, C., Wallace, L., Bowen, T., Topley, N., Taylor, P. and Fraser, D. 2015. Microrna regulation of macrophage phenotype in peritoneal fibrosis. Nephrology Dialysis Transplantation 30(iii262) (10.1093/ndt/gfv180.15)
• Bowen, T., Meran, S., Williams, A., Newbury, L., Sauter, M. and Sitter, T. 2015. Regulation of synthesis and roles of hyaluronan in peritoneal dialysis. BioMed Research International 2015, article number: 427038. (10.1155/2015/427038)

2014

• Vigetti, D. et al. 2014. Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation. Journal of Biological Chemistry 289(42), pp. 28816-28826. (10.1074/jbc.M114.597401)
• Khalid, U., Bowen, T., Fraser, D. and Jenkins, R. 2014. Acute kidney injury: a paradigm for miRNA regulation of the cell cycle. Biochemical Society Transactions 42(4), pp. 1219-1223. (10.1042/BST20140093)
• Jenkins, R. H. et al. 2014. miR-192 induces G2/M growth arrest in aristolochic acid nephropathy. American Journal of Pathology 184(4), pp. 996-1009. (10.1016/j.ajpath.2013.12.028)
• Midgley, A. C., Bowen, T., Phillips, A. O. and Steadman, R. 2014. MicroRNA-7 inhibition rescues age-associated loss of epidermal growth factor receptor and hyaluronan-dependent differentiation in fibroblasts. Aging Cell 13(2), pp. 235-244. (10.1111/acel.12167)

2013

• Benitez, A., Yates, T. J., Shamaldevi, N., Bowen, T. and Lokeshwar, V. B. 2013. Dietary supplement hymecromone and sorafenib: A novel combination for the control of renal cell carcinoma. The Journal of Urology 190(1), pp. 285-290. (10.1016/j.juro.2012.12.011)
• Midgley, A. C., Rogers, M. J., Hallett, M. B., Clayton, A., Bowen, T., Phillips, A. O. and Steadman, R. 2013. Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation Is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. Journal of Biological Chemistry 288(21), pp. 14824-14838. (10.1074/jbc.M113.451336)
• Bowen, T., Jenkins, R. H. and Fraser, D. J. 2013. MicroRNAs, transforming growth factor Beta-1, and tissue fibrosis. The Journal of Pathology 229(2), pp. 274-285. (10.1002/path.4119)

2012

• Jenkins, R. H., Martin, J., Phillips, A. O., Bowen, T. and Fraser, D. J. 2012. Transforming growth factor β1 represses proximal tubular cell microRNA-192 expression through decreased hepatocyte nuclear factor DNA binding. Biochemical Journal 443(2), pp. 407-416. (10.1042/BJ20111861)
• Bowen, T. 2012. A role for fibrocytes in peritoneal fibrosis?. Peritoneal Dialysis International 32(1), pp. 4-6. (10.3747/pdi.2011.00071)
• Jenkins, R. H., Martin, J., Phillips, A. O., Bowen, T. and Fraser, D. J. 2012. Pleiotropy of microRNA-192 in the kidney. Biochemical Society Transactions 40(4), pp. 762-767. (10.1042/BST20120085)
• Beltrami, C., Clayton, A., Phillips, A. O., Fraser, D. J. and Bowen, T. 2012. Analysis of urinary microRNAs in chronic kidney disease. Biochemical Society Transactions 40(4), pp. 875-879. (10.1042/BST20120090)
• Beltrami, C., Clayton, A., Phillips, A. O., Fraser, D. J. and Bowen, T. 2012. Analysis of urinary microRNAs in chronic kidney disease. Biochemical Society Transactions 40(4), pp. 875-879. (10.1042/BST20120090)

2011

• Michael, D. R. et al. 2011. The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell. Journal of Biological Chemistry 286(22), pp. 19523-19532. (10.1074/jbc.M111.233916)
• Martin, J., Jenkins, R. H., Bennagi, R., Krupa, A., Phillips, A. O., Bowen, T. and Fraser, D. J. 2011. Post-transcriptional regulation of transforming growth factor beta-1 by microrna-744. PLoS ONE 6(10), article number: e25044. (10.1371/journal.pone.0025044)
• Khammas, H., Bowen, T., Williams, J. D., Phillips, A. O., Steadman, R. and Martin, J. 2011. Characterisation of the human ADAM15 promoter. Nephron Experimental Nephrology 118(2), pp. e27-e38. (10.1159/000320698)

2009

• Simpson, R. M. L., Meran, S., Thomas, D. W., Stephens, P., Bowen, T., Steadman, R. and Phillips, A. O. 2009. Age-related changes in pericellular hyaluronan organization leads to impaired dermal fibroblast to myofibroblast differentiation. American Journal of Pathology 175(5), pp. 1915-1928. (10.2353/ajpath.2009.090045)
• Zhang, L. et al. 2009. Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: Contributory role in hyaluronan accumulation in thyroid dysfunction. Journal of Biological Chemistry 284(39), pp. 26447-26455. (10.1074/jbc.M109.003616)

2008

• Nair, S. et al. 2008. Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening. Journal of Nephology 21(3), pp. 400-405.

2007

• Meran, S., Thomas, D. W., Stephens, P., Martin, J., Bowen, T., Phillips, A. O. and Steadman, R. 2007. Involvement of hyaluronan in regulation of fibroblast phenotype. The Journal of Biological Chemistry 282(35), pp. 25687-25697. (10.1074/jbc.M700773200)
• Saavalainen, K., Tammi, M. I., Bowen, T., Schmitz, M. L. and Carlberg, C. 2007. Integration of the activation of the human hyaluronan synthase 2 gene promoter by common cofactors of the transcription factors retinoic acid receptor and nuclear factor kappaB. Journal of Biological Chemistry 282(15), pp. 11530-11539. (10.1074/jbc.M607871200)

2006

• Martin, J., Bowen, T. and Steadman, R. 2006. The pluripotent cytokine pleiotrophin is induced by wounding in human mesangial cells. Kidney International 70(9), pp. 1616-1622. (10.1038/sj.ki.5001800)
• Rashid Selbi, W., de la Motte, C. A., Hascall, V. C., Day, A. J., Bowen, T. and Phillips, A. O. 2006. Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney International 70(7), pp. 1287-1295. (10.1038/sj.ki.5001760)
• Monslow, J. et al. 2006. Sp1 and Sp3 mediate constitutive transcription of the human hyaluronan synthase 2 gene. The Journal of Biological Chemistry 281(26), pp. 18043-18050. (10.1074/jbc.M510467200)
• Bowen, T., Fulop, C., Rugg, M. S. and Selbi, W. 2006. Overexpression of hyaluronan synthase 2 alters hyaluronan distribution and function in proximal tubular epithelial cells. Journal of the American Society of Nephrology 17(6), pp. 1553-67. (10.1681/ASN.2005080879)

2005

• Topley, N., Michael, D. R. and Bowen, T. 2005. CA125: holy grail or a poisoned chalice. Nephron Clinical Practice 100(2), pp. c52-c54. (10.1159/000085033)

2004

• Monslow, J. et al. 2004. Identification and analysis of the promoter region of the human hyaluronan synthase 2 gene. The Journal of Biological Chemistry 279(20), pp. 20576-20581. (10.1074/jbc.M312666200)

2003

• Hoogendoorn, B., Coleman, S. L., Guy, C., Smith, S. K., Bowen, T., Buckland, P. R. and O'Donovan, M. C. 2003. Functional analysis of human promoter polymorphisms. Human Molecular Genetics 12(18), pp. 2249-2254. (10.1093/hmg/ddg246)
• Monslow, J. et al. 2003. The human hyaluronan synthase genes: genomic structures, proximal promoters and polymorphic microsatellite markers. The International Journal of Biochemistry & Cell Biology 35(8), pp. 1272-1283. (10.1016/S1357-2725(03)00048-7)

2002

• Williams, N. M. et al. 2002. Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor. Molecular Psychiatry 7(5), pp. 508-514. (10.1038/sj.mp.4001030)

2001

• Bowen, T. et al. 2001. Mutation screening of the KCNN3 gene reveals a rare frameshift mutation [Letter]. Molecular Psychiatry 6(3), pp. 259-260. (10.1038/sj.mp.4000128)

2000

• Vincent, J. B. et al. 2000. Long repeat tracts at SCA8 in major psychosis. American Journal of Medical Genetics 96(6), pp. 873-876. (10.1002/1096-8628(20001204)96:6<873::AID-AJMG37>3.0.CO;2-9)
• Bowen, T. et al. 2000. No evidence of association from transmission disequilibrium analysis of the hKCa3 gene in bipolar disorder. Bipolar Disorders 2(4), pp. 328-331. (10.1034/j.1399-5618.2000.020406.x)
• Bray, N. J. et al. 2000. No evidence for association between a non-synonymous polymorphism in the gene encoding human metabotropic glutamate receptor 7 and schizophrenia. Psychiatric Genetics 10(2), pp. 83-86. (10.1097/00041444-200010020-00005)
• Austin, J. et al. 2000. Comparative sequencing of the proneurotensin gene and association studies in schizophrenia. Molecular Psychiatry 5(2), pp. 208-212. (10.1038/sj.mp.4000693)
• Bowen, T. et al. 2000. Repeat sizes at CAG/CTG loci CTG18.1, ERDA1 and TGC13-7a in schizophrenia. Psychiatric Genetics 10(1), pp. 33-37. (10.1097/00041444-200010010-00006)
• Williams, N. et al. 2000. Identification and characterisation of SNPs in candidate genes for schizophrenia. American Journal of Medical Genetics - Neuropsychiatric Genetics 96(4), pp. 462.

1999

• Bowen, T. et al. 1999. Linkage studies of bipolar disorder with chromosome 18 markers. American Journal of Medical Genetics 15(88), pp. 503-509. (10.1002/(SICI)1096-8628(19991015)88:5<503::AID-AJMG13>3.0.CO;2-U)
• Williams, N. M., Bowen, T., Kirov, G., Williams, H., Hoogendorn, B., Asherson, P. and Owen, M. J. 1999. Polymorphism screening and association studies of the Wolfram syndrome gene in schizophrenia. Molecular Psychiatry 4(supp1), pp. S42-S42.
• Guy, C., Bowen, T., Jones, I. R., McCandless, F., Owen, M. J., Craddock, N. J. and O'Donovan, M. C. 1999. CTG18.1 and ERDA-1 CAG/CTG repeat size in bipolar disorder. Neurobiology of Disease 6(4), pp. 302-307. (10.1006/nbdi.1999.0249)
• Cardno, A. G. et al. 1999. CAG repeat length in the hKCa3 gene and symptom dimensions in schizophrenia. Biological Psychiatry 45(12), pp. 1592-1596. (10.1016/s0006-3223(99)00033-5)
• Franks, E., Guy, C., Jacobsen, N., Bowen, T., Owen, M. J., O'Donovan, M. C. and Craddock, N. J. 1999. Eleven trinucleotide repeat loci that map to chromosome 12 excluded from involvement in the pathogenesis of bipolar disorder. American Journal of Medical Genetics 88(1), pp. 67-70. (10.1002/(SICI)1096-8628(19990205)88:1<67::AID-AJMG12>3.0.CO;2-#)
• Guy, C. et al. 1999. No association between a polymorphic CAG repeat in the human potassium channel gene hKCa3 and bipolar disorder. American Journal of Medical Genetics 88(1), pp. 57-60. (10.1002/(sici)1096-8628(19990205)88:1%3C57::aid-ajmg10%3E3.0.co;2-6)

1998

• Bowen, T. et al. 1998. Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophrenia. Molecular Psychiatry 3(3), pp. 266-269. (10.1038/sj.mp.4000400)
• Bowen, T. et al. 1998. Linked polymorphisms upstream of exons 1 and 2 of the human cholecystokinin gene are not associated with schizophrenia or bipolar disorder. Molecular Psychiatry 3(1), pp. 67-71. (10.1038/sj.mp.4000293)
• Cardno, A. G. et al. 1998. Association between functional psychosis and expanded CAG/CTG repeats is not explained by health stratification [comparative study]. Psychiatric Genetics 8(1), pp. 29-32. (10.1097/00041444-199800810-00005)

1997

• Guy, C. et al. 1997. Exclusion of expansion of 50 CAG/CTG trinucleotide repeats in bipolar disorder. American Journal of Psychiatry 154(8), pp. 1146-1147.
• Speight, G. et al. 1997. Exclusion of CAG/CTG trinucleotide repeat loci which map to chromosome 4 in bipolar disorder and schizophrenia. American Journal of Medical Genetics 74(2), pp. 204-206. (10.1002/(SICI)1096-8628(19970418)74:2<204::AID-AJMG19>3.0.CO;2-M)

1996

• O'Donovan, M. C. et al. 1996. Confirmation of association between expanded CAG/CTG repeats and both schizophrenia and bipolar disorder. Psychological Medicine -London- 26(6), pp. 1145-1153. (10.1017/s0033291700035868)
• Bowen, T. et al. 1996. Expansion of 50 CAG/CTG repeats excluded in schizophrenia by application of a highly efficient approach using repeat expansion detection and a PCR screening set. American Journal of Human Genetics 59(4), pp. 912-917.